The Promise of Immunotherapy in Treating Advanced Prostate Cancer

Published on

Topics include: Treatments

There is continuing excitement about immunotherapy—which harnesses the body’s immune system—and its promise in treating a variety of cancers.

Dr. Sumit Subudhi, from MD Anderson Cancer Center, joined Patient Power to help explain how immunotherapy works and what approved and developing approaches could mean for men with advanced prostate cancer.

Sponsored by the Patient Empowerment Network through an educational grant from Sanofi and an independent educational grant from Astellas and Medivation, Inc. Produced in association with The University of Texas MD Anderson Cancer Center.

View more programs featuring

Produced in association with , and

Related Programs

What Could Emerging Prostate Cancer Research Mean for Patients?

Dr. Neal Shore, a leading prostate cancer expert, shares his perspective on news from ASCO 2015.


An Expert’s Perspective on Developing Prostate Cancer Research

Dr. Karim Fizazi shares his reflections on ASCO 2015 explains what new developments could mean for patients.


Treatment Arsenal for Prostate Cancer Expands

Will men with prostate cancer live longer if given chemotherapy early on? Dr. Heather Cheng talks about why early treatment makes an enormous difference in a subset of men with prostate cancer.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on December 23, 2015